Follow-up of patients with a thin melanoma

British Journal of Surgery

Volumn 86, Issue 5, 1999, Pages 619-621

  Johnson, R C ^a,b,c   Fenn, N J ^a,b   Horgan, K ^a,b   Mansel, R E ^a,b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; STATISTICAL ANALYSIS; SURVIVAL RATE; THICKNESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS; TIME FACTORS;

EID: 0004306553     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.1999.01079.x     Document Type: Article

References (22)

1. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-8.
2. Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Trends in tumour characteristics and survival of malignant melanoma 1960-84: a population-based study in Sweden. Br J Cancer 1994; 70: 743-8.
3. Woods JE, Soule EH, Creagan ET. Metastasis and death in patients with thin melanomas (less than 0-76 mm). Ann Surg 1983; 198: 63-4.
4. Briele HA, Beattie CVV, Ronan SG, Chaudhuri PK, Das Gupta TK. Late recurrence of cutaneous melanoma. Arch Surg 1983; 118: 800-3.
5. Gutman JVI, Klausner JM, InbarM, Rozin RR. Late recurrence of stage I malignant melanoma. J Surg Oncol 1989; 42: 96-8.
6. Baughan CA, Hall VL, Leppard BJ, Perkins PJ. Follow-up in stage I cutaneous malignant melanoma: an audit. Clin Oncol (R Coll Radial) 1993; 5: 174-80.
7. Shumate CR, Urist ALM, Aladdox WA. Melanoma recurrence surveillance: Patient or physician based? Ann Surg 1995; 221: 566-71.
8. Alansson Brahme E, Carstensen J, Erhardt K, Lagerlof B, Ringborg U, Rutqvist LE. Prognostic factors in thin cutaneous malignant melanoma. Cancer 1994; 73: 2324-32.
9. O'Connor WJ, Barnes L. Melanoma - a five year audit. Ir Med } 1994; 87: 138-9.
10. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biological behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-27.
11. Karjalainen J, Eskelinen M, Kosma V-M, Lipponen P, Tuominen L, Alhava E. Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma. Anticancer Res 1992; 12: 1507-11.
12. Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE et al. A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group. Ann Intern Med 1996; 125: 369-75.
13. Kelly JW, Sagebiel RW, Clyman S, Blois MS. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator. Ann Surg 1985; 202: 98-103.
14. Dang CL Jr, Mihm MC Jr, Sober AJ, Harris MN, Kopf AW, Fitzpatrick TB et al. Prognostic factors for melanoma patients with lesions 0-76-1-69 in thickness. An appraisal of 'thin' level IV lesions. Ann Surg 1982; 195: 30-}.
15. Garbe C, Buttner P, Bertz G, Burg G, d'Hoedt B, Drepper H et al. Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer 1995; 75: 2492-8.
16. Slingluff CL Jr, Seigler HE. 'Thin' malignant melanoma: risk factorsand clinical management. Ann Plast Surg 1992; 28:89-94.
17. Pontikes LA, Temple WJ, Cassar SL, Lafreniere R, Huchcroft SA, Jerry LAI et al. Influence of level and depth on recurrence rate in thin melanomas. Am J Surg 1993; 165: 225-8.
18. Graham CH, Rivers J, Kerbel RS, Stankiewicz KS, White WL. Extent of vascularization as a prognostic indicator in thin (< 0-76 mm) malignant melanoma. Am J Patbol 1994; 145: 510-14.
19. Slingluff CL Jr, Vollmer RT, Reintgen DS, Seigler HF. Lethal 'thin' malignant melanoma. Identifying patients at risk. Ann Surg 1988; 208: 150-61.
20. Buttner P, Garbe C, Bertz J, Burg G, D'Hoedt B, Drepper H et al. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 1995; 75: 2499-506.
21. Guerry D IV, Synnestvedt M, Elder DE, Schultz D. Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. J Invest Dennatol 1993; 100: 342-5s.
22. Clark WH Jr, Elder DE, Guerry D IV, Braitman LE, Trock BJ, Schultz D et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893-904.